7T Gummy ES Chewable Tablets Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with 7T Gummy ES Chewable Tablets
O
- Ocella (drospirenone / ethinyl estradiol)
- Octocaine 100 (epinephrine / lidocaine)
- Ogestrel 0.5 / 50 (ethinyl estradiol / norgestrel)
- olutasidenib
- omaveloxolone
- Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine)
- Omnihist L.A. (chlorpheniramine / methscopolamine / phenylephrine)
- Oncaspar (pegaspargase)
- Onsura (ethinyl estradiol / norelgestromin)
- Optimum Charcoal (charcoal)
- Orabloc (articaine / epinephrine)
- Orbivan (acetaminophen / butalbital / caffeine)
- Orbivan CF (acetaminophen / butalbital)
- Orsythia (ethinyl estradiol / levonorgestrel)
- Ortho Cyclen (ethinyl estradiol / norgestimate)
- Ortho Evra (ethinyl estradiol / norelgestromin)
- Ortho Tri-Cyclen (ethinyl estradiol / norgestimate)
- Ortho Tri-Cyclen Lo (ethinyl estradiol / norgestimate)
- Ortho-Cept (desogestrel / ethinyl estradiol)
- Ortho-Novum 1 / 35 (ethinyl estradiol / norethindrone)
- Ortho-Novum 1 / 50 (mestranol / norethindrone)
- Ortho-Novum 10 / 11 (ethinyl estradiol / norethindrone)
- Ortho-Novum 7 / 7 / 7 (ethinyl estradiol / norethindrone)
- Oscimin (hyoscyamine)
- Oshih (ethinyl estradiol / norethindrone)
- ospemifene
- Osphena (ospemifene)
- Otrexup (methotrexate)
- Ovcon 35 (ethinyl estradiol / norethindrone)
- Ovcon 35 Fe (ethinyl estradiol / norethindrone)
- Ovcon 50 (ethinyl estradiol / norethindrone)
- Ovral (ethinyl estradiol / norgestrel)
- Ovral-21 (ethinyl estradiol / norgestrel)
- Ovral-28 (ethinyl estradiol / norgestrel)
- oxazepam
- oxybutynin
- Oxytrol (oxybutynin)
- Oxytrol for Women (oxybutynin)
More about 7T Gummy ES Chewable Tablets (acetaminophen)
- Check interactions
- Compare alternatives
- Latest FDA alerts (16)
- Side effects
- Dosage information
- During pregnancy or Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.